Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

Alaska Air Group, Inc. ALK: This airline company has seen the Zacks Consensus Estimate for its current year earnings increasing 19% over the last 60 days.

Alaska Air Group, Inc. Price and Consensus

Alaska Air Group, Inc. price-consensus-chart | Alaska Air Group, Inc. Quote

Ashford Hospitality Trust, Inc. AHT: This real estate investment trust firm has seen the Zacks Consensus Estimate for its current year earnings increasing 86.5% over the last 60 days.

Ashford Hospitality Trust Inc Price and Consensus

Ashford Hospitality Trust Inc price-consensus-chart | Ashford Hospitality Trust Inc Quote

NRx Pharmaceuticals, Inc. NRXP: This bio-pharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 46.2% over the last 60 days.

NRx Pharmaceuticals, Inc. Price and Consensus

NRx Pharmaceuticals, Inc. price-consensus-chart | NRx Pharmaceuticals, Inc. Quote

Pro-Dex, Inc. PDEX: This medical device contract manufacturer company has seen the Zacks Consensus Estimate for its current year earnings increasing 40.9% over the last 60 days.

Pro-Dex, Inc. Price and Consensus

Pro-Dex, Inc. price-consensus-chart | Pro-Dex, Inc. Quote

eGain Corporation EGAN: This customer service infrastructure software company has seen the Zacks Consensus Estimate for its current year earnings increasing 77.8% over the last 60 days.

eGain Corporation Price and Consensus

eGain Corporation price-consensus-chart | eGain Corporation Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. 

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Ashford Hospitality Trust Inc (AHT) : Free Stock Analysis Report

Alaska Air Group, Inc. (ALK) : Free Stock Analysis Report

eGain Corporation (EGAN) : Free Stock Analysis Report

Pro-Dex, Inc. (PDEX) : Free Stock Analysis Report

NRx Pharmaceuticals, Inc. (NRXP) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research